Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.56828 | 23 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.52602 | 23 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.52691 | 22 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.46661 | 22 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.46041 | 22 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.74373 | 29 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.6819 | 28 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.50488 | 22 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.4864 | 22 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.51518 | 22 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.51209 | 22 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.4916 | 22 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.07886 | 46 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.51584 | 22 |